Cholangiocarcinoma discoveries and treatment approaches Aug. 28, 2021 Overview Mostrar la transcripción Overview Cholangiocarcinoma remains a surgical disease, but even with a successful resection the recurrence rate is about 70%. Rory L. Smoot, M.D., surgical oncologist at Mayo Clinic’s campus in Rochester, Minnesota, is an expert on cholangiocarcinoma and other biliary tract cancers. Hear Dr. Smoot discuss the systemic treatments and next-generation sequencing done at Mayo Clinic to extend patients’ lives while even more treatment discoveries are being made. VID-20520779 Profesionales médicos Cholangiocarcinoma discoveries and treatment approaches